MedTrace Logo

Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy

NCT04774198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2025-04-06

No results posted yet for this study

Summary

Perioperative immunologic signatures can predict the risk of postoperative complications.

The results will be puplished as two smanuscripts. The manuscript will focus on preoperative immunologisk data,the second manuscript will include both pre- and postoperative data.

Conditions

  • Pancreas Cancer

Interventions

DIAGNOSTIC_TEST

blood sample

Blood samples are collected within 24 hours before the surgical procedure, on postoperative day two and seven. Samples collected are as following: TruCulture, flow cytometry, markers of systemic inflammation (Plasma level of pro- and anti-inflammatory molecules assed by Olink inflammation panel, leucocytes, differential count, hemoglobin, thrombocytes and CRP)

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Eske K Aasvang, DMSci · Rigshospitalet, Denmark

  • Sisse R Ostrowski, DMSci · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2023-12-07
Completion
2024-01-07

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774198 on ClinicalTrials.gov